Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) 

Guerbet obtains one million euros of public funding from Bpifrance (France 2030 investment plan) 

For a project developing artificial intelligence for the early detection of pancreatic cancer

Read the press release
Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

Guerbet announces U.S. Food and Drug Administration (FDA) approval of Elucirem™ (Gadopiclenol)

Read the press release
Why professionals have chosen icobrainand what are its added values?

Why professionals
have chosen icobrain
and what are
its added values?

Feedback on icobrain in clinical routine from
Dr. Florence Beuret and Mr. Samir Lounis

Learn more
CIRSE 2022

Interventional Radiology Congress

CIRSE 2022

We are pleased to participate in CIRSE 2022 (Cardiovascular and Interventional Radiological Society of Europe), which will be held both virtually and onsite in Barcelona from September 10th to 14th.

Learn more
Image Scan Min

Nearly a century of passion and dedication

Guerbet has become one of the leading experts in medical imaging worldwide. Collectively, we offer a full range of medical solutions and services in diagnostic imaging and interventional imaging.

Learn more about Guerbet

Discover the latest news of Guerbet

Latest news

Banner For PR March 7

Guerbet expands portfolio with microcatheters and guidewires for interventional imaging and embolization

Read the press release
Banner DEF

Guerbet and Bracco Imaging Announce a Global Strategic Collaboration Agreement for Gadopiclenol

Read the press release
Gaia Index Press Release Min

Gaïa-Index 2021: Guerbet consolidates its position as a leader in the “Healthcare” category

Read the press release